BioSyntech, Inc.
BSYI · OTC
12/31/2009 | 9/30/2009 | 6/30/2009 | 3/31/2009 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -99.6% | 119.2% | 132% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -80.4% | 67.7% | 59.3% | 69.7% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $1 | $1 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | $1 | $1 | $3 |
| Operating Expenses | $3 | $4 | $3 | $5 |
| Operating Income | -$3 | -$4 | -$3 | -$4 |
| % Margin | -656,102.4% | -2,974.8% | -4,764.8% | -18,936.9% |
| Other Income/Exp. Net | $3 | $4 | $3 | $4 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$4 | -$3 | -$3 |
| % Margin | -664,083.3% | -3,007.2% | -4,837.7% | -12,955% |
| EPS | -0.032 | -0.032 | -0.035 | -0.031 |
| % Growth | 2.8% | 6.9% | -11.9% | – |
| EPS Diluted | -0.032 | -0.032 | -0.035 | -0.031 |
| Weighted Avg Shares Out | 106 | 105 | 101 | 99 |
| Weighted Avg Shares Out Dil | 106 | 105 | 101 | 99 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$3 | -$3 | -$4 |
| % Margin | -638,779.8% | -2,898.3% | -4,582.1% | -18,540.1% |